Related Experiment Videos
Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals
F Durazo1, F Resano, M A Gonzalez
1Hospital Mocel, Mexico City, Mexico.
Diagnostic Microbiology and Infectious Disease
|January 1, 1990
Abstract:
A new difluorinated quinolone, lomefloxacin, was shown to have potent in vitro activity against a broad spectrum of bacteria, including multiresistant strains isolated from patients with severe infections in three hospitals in Mexico City. Whereas its activity was comparable to that of another fluoroquinolone (enoxacin), the pharmacokinetic advantages offered by lomefloxacin may be a significant benefit in clinical use.